# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Jazz Pharmaceuticals (NASDAQ: JAZZ), a drug company behind the CBD-based medication Epidiolex, recently filed a lawsuit against...
Epileptic seizure frequency fell by an average of 86% among ten children treated with whole-plant medicinal cannabis, reveals a...
Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a global biopharmaceutical company, announced its financial results Tuesday afternoon ...
Biopharmaceutical company Jazz Pharmaceuticals plc (NASDAQ: JAZZ) reported its financial results on Tuesday for the second quar...
Cannabis operators and executives tell Benzinga that the movement of private and public companies may serve as a better indicat...
Below is a recap of the main news related to the cannabis industry and markets for the week of June 28, 2021.
The Global Cannabis Stock Index fell for the fourth straight month, dropping 4.1% to 57.10. During the second quarter, the ind...
2021 seems to be the year of cannabis, as its prospects and apparent societal acceptance have dramatically changed since the in...
This was an eventful week for the cannabis industry.